Early Deaths after Arterial Ischemic Stroke in Pediatric Patients: Incidence and Risk Factors

Ilona Kopyta1, Agnieszka Cebula1, Beata Sarecka-Hujar2

  • 1Department of Paediatric Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Medykow Str 16, 40-752 Katowice, Poland.

Insights

Pediatric arterial ischemic stroke (AIS) mortality has declined, but early death risk factors remain unclear. Understanding these factors is crucial for prognosis and timely patient supervision in childhood stroke cases.

Area of Science:

  • Neurology
  • Pediatrics
  • Public Health

Background:

  • Cerebrovascular diseases are a leading cause of death in developed countries for both pediatric and adult populations.
  • Arterial ischemic stroke (AIS) in children has a variable mortality rate, ranging from 1% to nearly 32% in different studies.
  • While pediatric stroke mortality shows a declining trend, significant variability exists due to factors like healthcare access, age, ethnicity, and stroke etiology.

Purpose of the Study:

  • To analyze and discuss current literature on the incidence of early death in pediatric stroke.
  • To identify and discuss risk factors associated with early mortality in children experiencing stroke.

Main Methods:

  • Systematic review of existing literature on pediatric stroke outcomes.
  • Analysis of reported incidence of early death in pediatric arterial ischemic stroke (AIS).
  • Identification and synthesis of risk factors for early mortality based on published pediatric stroke case series.

Main Results:

  • The prevalence of fatal outcomes in pediatric AIS varies widely across studies.
  • A general trend of decreasing mortality rates in childhood stroke has been observed.
  • Early death risk factors in pediatric stroke are not well-established, often derived from small patient cohorts.

Conclusions:

  • Further research is needed to fully understand the drivers of variability in pediatric stroke mortality.
  • Identifying early risk factors for death in pediatric stroke is critical for improving patient prognosis.
  • Enhanced understanding of these factors can aid in the early selection of pediatric stroke patients requiring intensive monitoring and care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
64
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
122
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
108
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
558